Summary
The effects of dilazep, a drug which potentiates the actions of adenosine, were examined in a canine preparation that enabled simultaneous measurements to be made of blood flow both in ischaemic areas, and in essentially normal areas, of the canine myocardium. In doses which caused marked and sustained increases in blood flow to the normal myocardium, dilazep did not change either blood flow in the developing infarct or the trans-ventricular perfusion pressure (diastolic peripheral coronary pressure minus left ventricular end-diastolic pressure). Despite the lack of effect on infarct blood flow, the oxygen tension of the blood draining the infarcting area was markedly elevated. It is concluded that dilazep may open up blood vessels in an acutely ischaemic area which do not take part in tissue exchange, and may therefore decrease the efficiency of the myocardial circulation.
Similar content being viewed by others
References
Behrenbeck, D. W., Wagner, J., Hellwig, H., Grenzmann, M., Hilger, H. H.: Die Wirkung eines Trimethoxybenzoesäurederivates auf die Koronardurchblutung beim Menschen. Verh. dtsch. Ges. Kreisl.-Forsch. 34, 287–292 (1968)
Buyniski, J. P., Losada, M., Bierwagen, M. E., Gardier, R. W.: Cerebral and coronary vascular effects of a symmetrical N,N′-disubstituted hexahydrodiazepine. J. Pharmacol. exp. Ther. 181, 522–528 (1972)
Deuticke, B., Gerlach, E.: Abbau freier Nucleotide in Herz, Skeletmuskel, Gehirn und Leber der Ratte bei Sauerstoffmangel. Pflügers Arch. ges. Physiol. 292, 239–254 (1966)
Eliška, O., Elišková, M.: Arterial and venous circulation in ischaemic foci in the myocardium. Angiologica 7, 65–76 (1970)
Fisher, W., Heimbach, D., Ledingham, I. McA., Marshall, R. J., Parratt, J. R.: Blood flow and oxygen extraction in ischaemic and normal regions of the myocardium following acute coronary artery ligation. J. Physiol. (Lond.) 230, 15–17P (1973)
Hilger, H. H., Behrenbeck, D. W., Hellwig, H., Wagner, J.: Investigation on the effect of coronary vasodilator drugs on coronary blood flow in man. Pharmacol. Clin. 1, 77–89 (1968)
Ledingham, I. McA., Marshall, R. J., Parratt, J. R.: Drug induced changes in blood flow in normal and ischaemic regions of the canine myocardium. Brit. J. Pharmacol. 47, 626–627P (1973)
Ledingham, I. McA., McBride, T. I., Parratt, J. R., Vance, J. P.: The effect of hypercapnia on myocardial blood flow and metabolism. J. Physiol. (Lond.) 210, 87–105 (1970)
Marshall, R. J., Ledingham, I. McA., Parratt, J. R.: Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc. Res. (in press) (1974)
Marshall, R. J., Parratt, J. R.: The effect of noradrenaline on blood flow and oxygen consumption in normal and ischaemic areas of myocardium. Amer. Heart J. 86, 653–662 (1973a)
Marshall, R. J., Parratt, J. R.: The effect of dipyridamole on blood flow and oxygen handling in the acutely ischaemic and normal canine myocardium. Brit. J. Pharmacol. (in press) (1973b)
Parratt, J. R., Ledingham, I. McA., McArdle, C. S.: The effect of a coronary vasodilator drug (carbochromen) on blood flow and oxygen extraction in acute myocardial infarction. Cardiovasc. Res. 7, 446–457 (1973)
Rubio, R., Berne, R.: Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance. Circulat. Res. 25, 407–415 (1969)
Sano, N., Katsuki, S., Kawada, M.: Enhancement of coronary vasodilator action of adenosine by 1,4-Bis-[3,4,5-trimethoxybenzoyl-oxy)-propyl]-perhydro-1,4-diazepine (Dilazep I.N.N.). Arzneimittel-Forsch. 22, 1655–1658 (1972)
Severinghaus, J. W., Blood gas calculator. J. appl. Physiol. 21, 1108–1116 (1966)
Tillich, G., Mendoza, L., Bing, R. J.: Total and nutritional coronary flow. Circulat. Res. 28/29 Suppl. 1, 148–153 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marshall, R.J., Parratt, J.R. The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Naunyn-Schmiedeberg's Arch. Pharmacol. 281, 427–436 (1974). https://doi.org/10.1007/BF00499437
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00499437